The British Veterinary Association has welcomed the British Veterinary Nursing Association and the Veterinary Practice Management Association as Affiliate members.
Affiliate and Associate are newly activated BVA membership categories, and the election of BVNA and the VPMA as Affiliates also encourages any of their suitably qualified members to apply for Associate membership of the BVA.
According to the BVA, Affiliate status in no way affects an organisation's own remit and responsibilities towards its members. What it does mean is that Affiliates can benefit from the BVA's knowledge and expertise in such areas as lobbying and marketing.
In welcoming BVNA and VPMA newly elected BVA President Nicky Paull said: "I am delighted that my Presidential year coincides with the BVA family embracing both veterinary nurses and veterinary practice managers. Both are integral members of the veterinary team and we believe that our new relationship will bring lasting benefits to all parties. BVA looks forward to supporting our new Affiliates in promoting the professionalism of both veterinary nursing and veterinary practice management not only within the profession but to the wider community.
These are exciting, if challenging times, for the veterinary community world-wide and I have no doubt that our new relationship will strengthen not only our individual associations but the profession as a whole."
The British Veterinary Association and its specialist cattle division the British Cattle Veterinary Association have welcomed today's announcement by Defra that it is strongly minded to include a controlled cull of badgers as a key component of the bovine tuberculosis (TB) eradication plans for England.
The two associations have long supported the need to control TB in both cattle and wildlife, including the need for a targeted, humane cull of badgers in specific parts of the country.
Following a consultation exercise which closed in December 2010, Defra has today announced:
The BVA and BCVA jointly responded to Defra's 2010 consultation to say that the available science supported the case for a badger cull, alongside the need for stricter cattle control measures, in those areas where badgers are regarded as a significant contributor to the persistent presence of TB. The response also emphasised strongly that any cull of badgers had to be done in a humane and effective manner.
The BVA and BCVA say that today's announcement shows Defra has listened closely to their concerns. Through the consultation response the BVA and BCVA raised the issue of the efficacy of an industry-led cull using controlled shooting (as opposed to cage trapping and shooting) and stated firmly that any cull must be monitored for humaneness. Both of these issues have been considered in depth by Defra and appear to have been addressed in the plans.
The associations say they will be looking closely at the detail of the guidance issued today and will be responding to the consultation.
Harvey Locke, President of the BVA, said: "The BVA and BCVA have long argued for a targeted, humane badger cull to be used alongside stricter cattle controls. We believe that failure to tackle wildlife sources of TB infection has prolonged the presence and enhanced the spread of infection in all affected species populations.
"We recognise that this is a very emotive and difficult decision but we believe that the science supports this policy and we support Defra's commitment to tackling this devastating disease.
"We are particularly pleased that this announcement has not been delayed until after the summer recess, which demonstrates the seriousness of the need to tackle TB."
John Fishwick, President of BCVA, added: "We welcome today's announcement which indicates that a humane and carefully targeted cull of badgers can contribute to the control of this dreadful disease.
"We are particularly pleased that the veterinary profession's concerns that any cull must be humane and well monitored appear to have been listened to and we will now study the proposals in detail.
"An industry-led cull will be an enormous undertaking for everyone involved and it is vital that we get the detail right from the outset; for the sake of cattle, wildlife and industry."
Meanwhile, the RSPCA has expressed its devastation at the announcement.
According to the charity, new research has been published which shows that badger culling can more than double the risk of TB infecting cattle1. High-profile voices such as Sir David Attenborough and government adviser Lord John Krebs have also weighed in, saying a cull could "make the situation worse" and be "ineffective".
David Bowles, Director of Communications for the RSPCA, said: "Today is a black day for badgers - a day we have been dreading.
"At a time when the Welsh government has stepped back from a cull, the government in England is slowly shredding its own animal welfare credentials."
The RSPCA says it agrees that action is needed to combat bovine TB in cattle, but does not think action is synonymous with culling. The charity believes that vaccination of badgers, increased levels of testing, improved biosecurity and stricter controls on the movement of cattle are more effective ways of dealing with the problem in the long-term and eradicating bovine TB in cattle for good.
Colin Booty, senior scientist for the RSPCA, said: "The RSPCA is sympathetic to farmers struggling to cope with the effects of this crippling disease and thinks that the problem of bovine TB in cattle needs a sustainable and effective solution.
"But this is not such a solution. We believe that the government have taken the wrong fork in the road with this risky policy.
"This cull will contribute little or nothing to the long-term goal of eradicating TB nationally. Instead it will wipe out huge numbers of this much-loved species, including many animals which are healthy."
1 The New Medical Research Council study came from Imperial College London and were published in the Royal Society Journal Biology Letters. They were based on analysis of data from the 10-year Randomised Badger Culling Trial set up by the Department for Environment, Food and Rural Affairs (Defra) in 1998.
VetSurgeon member Neil Forbes FRCVS, Specialist in Avian Medicine at Vets Now Referrals, has been dealing with a rather interesting case: an owl that swallowed a sock.
John Dowling, the owner of a falconry business and keeper of the 13 week old Indian eagle owl called Lydon noticed he was not eating properly, and then looked dazed and confused when taking part in the Stonehouse Horticultural Show & Summer Jolly. After the show, Lydon looked like he was trying to vomit but couldn't, so John took him to Vets Now Referrals in Swindon for a consultation.
Neil examined Lydon and found there was a hard swelling in his abdomen. Radiographs confirmed a bloated and very full stomach. The decision was taken to operate on Lydon to remove whatever was inside. Fearing a growth or tumour, Neil was rather surprised to find instead a smelly old sock in Lydon's stomach. With the sock successfully removed, Lydon was able to go home a few hours later, none the worse for his experience.
Lydon's owner, John, said: "Lydon is a hand-reared Indian eagle and is often in and around the house. The sock is a toy he has played with since he was a owlet, and never did I think he would, or could, have eaten it!
"I was obviously surprised when Neil found the sock in Lydon's stomach but more relieved than anything. I feared the worst but was delighted to find out it wasn't something more sinister."
Neil said: "Never in my 28 years of avian medicine experience have I treated an owl that swallowed a sock, it's just unheard of. Thankfully John brought Lydon into our clinic for a consultation upon suspicion something wasn't quite right and we were able to remove the sock preventing further health deterioration.
"We would always advise owners of pets to be careful when leaving items around the house, as you can never predict how mischievous pets can be."
Carl Padgett has been elected President of the British Veterinary Association for 2011/2012.
Carl graduated from Glasgow University in 1989 and spent most of his career as a large animal practitioner. He is now a director of Bay Vets Ltd in Lancaster, and has particular interests in cattle health, production and welfare, veterinary politics and the role the profession has to play in the wider livestock industry and the companion animal world.
A former president of the British Cattle Veterinary Association (BCVA) and recent Chairman of Trustees of the BVA Animal Welfare Foundation, Carl has been involved in veterinary politics for over 15 years.
Carl said: "My representative roles for BVA, and prior to that BCVA, have enabled me to understand and realise my interest in the veterinary profession: ensuring the profession has a voice and our place in society is valued.
"Our multi-disciplinary education and training places the profession in a unique position to deliver a healthy future at many levels: representing the health and welfare of animals committed to our care, protecting the consumer by ensuring food safety and security at national and international levels by working within the agricultural world and ensuring public health in a variety of ways. Vets are not just part of the leisure industry making animals better; we fill a much wider role in underpinning society and its contact with animals at all levels."And so to the future. Although we do indeed live in a changing world, many of the challenges we face as a profession continue through from one President to the next, as they span beyond the year-long term of office. Over the last couple of years BVA has made a lot of progress on a number of policy issues and, in some instances, our lobbying efforts have paid off with Government announcements and new legislation reflecting our endeavours. Looking ahead, much of the coming year will be about putting those policies into practice, and that's why the theme of my presidential year will be 'Delivering a healthy future'.
"I am proud and honoured to be elected BVA President to continue serving the membership as part of the BVA Officer team."
Peter Harlech Jones was elected BVA President-elect for 2011/2012 at the same time.
A review of past research papers on the treatment of feline diabetes carried out by Dr Stijn Niessen at the RVC has found that much of the research into the condition was based on low-level evidence, lacked a cooperative approach and, therefore, yielded questionable results.
According to Dr Niessen, current recommendations are often based on previous research studies which used small sample sizes; some included as little as 8 cats. The biggest sample sizes found contained from 50 to 60 cats, but Dr Neissen says that even this isn't a big enough sample size to yield effective results. He says that so-called power calculations, a statistical test performed as part of this new publication, indicate that at least 80-90 animals are needed to accurately compare the effectiveness of different insulin types and other treatments.
Stijn said: "The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.
"This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits.
"Current research into the condition is sporadic, lacking a long-term vision and not collaborative. A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition. The owner could then go online and find a third way. These treatments aren't necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way. This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."
For more information, visit: https://www.facebook.com/RVC.Diabetic.Remission.Clinic
The British Equine Veterinary Association (BEVA) is urging veterinary surgeons to be on the lookout for outbreaks of Atypical Myopathy (AM) this spring.
Atypical Myopathy is a serious muscle disease found in the UK and Northern Europe. It is linked to horses eating the seeds from trees in the Acer family, including sycamore and box elder. There were more than five times as many cases of AM last autumn than in the previous year and experts have warned that the disease tends to occur more frequently in the spring following an autumn surge, possibly because of the growth of seedlings. The prognosis is poor, with survival rates of less than 25%. Early diagnosis is essential to give the best chance of survival.
Horses that develop AM are usually kept on sparse pastures, near trees from Acer pleudoplatanus (sycamore) or Acer negundo (box elder, pictured right) that shed seeds containing the toxin hypoglycin A. They are often not fed any supplementary hay or feed and may be driven to browse on an accumulation of dead leaves, dead wood and trees in or around the pasture but sometimes well-fed animals are affected. While the tree seeds may not be directly palatable, horses on poor quality grazing may ingest considerable numbers of them.
The clinical signs of AM may include muscle weakness or stiffness, colic-like symptoms, laboured breathing, dark red-brown urine, recumbency or even sudden death. Often the disease will present as an outbreak. Confirmation of diagnosis is by a blood or urine test. The toxin directly targets aerobic energy metabolism so therapy should be targeted at promoting glucose metabolism and provided fluid dieresis.
Preventative advice for horse owners includes:
Professor Celia Marr, Partner at Rossdales, Newmarket, European Specialist in Equine Internal Medicine and Editor of Equine Veterinary Journal said: "New, collaborative research, instigated last year between the University of Liege, the Irish Equine Centre and the Animal Health Trust should shed more light on the characteristics of the disease in this country. Once we know more about the specific causes we should be able to make more positive progress with prevention strategies."
BEVA has provided free online access to two articles from the journal of Equine Veterinary Education on the disease for all vets to help them address the threat.
Volume 25, Issue 5, pages 264-270, May 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 1: First aid, cardiovascular, nutritional and digestive care (pages 264-270) G. van Galen and D -M Votion.
Volume 25, Issue 6, pages 308-314, June 2013
Management of cases suffering from atypical myopathy: Interpretations of descriptive, epidemiological and pathophysiological findings. Part 2: Muscular, urinary, respiratory and hepatic care, and inflammatory/infectious status (pages 308-314) G van Galen and D - M Votion.
The annual minimum requirement for vets will be reduced from 35 to 26 hours of CPD, while that of veterinary nurses will be reduced from 15 to 11 hours. The reduction comes into force immediately.
A similar 25% reduction will also be introduced for veterinary surgeons holding Advanced Practitioner or RCVS Specialist status.
The decision to reduce the hours was made by the new RCVS Council COVID-19 Taskforce, chaired by RCVS President Dr Niall Connell, which was set up in order to make temporary policy decisions related to the pandemic in a quicker and more agile way. The proposal had previously been considered and supported by the RCVS Education Committee, VN Council and CPD Policy Working Group.
Niall said: “A number of veterinary surgeons and veterinary nurses expressed concern that it may be difficult to undertake CPD at present and so, in order to give the professions some breathing space, we decided we would reduce the minimum hours required for 2020. We also recognise that some practices are having to make the difficult decision to reduce their CPD budgets this year in response to falling footfall.
"However, it is worth reiterating that CPD need not be expensive or require physical attendance at lectures, congresses or other events. There are many online providers of CPD and other resources such as articles and webinars, some of which may be free. The key is that the CPD is relevant to you and enhances your professional practice and so we would still encourage all our members to undertake CPD as and when they can."
The policy will be under regular review and may be extended further if the circumstances demand. Those with any questions on the policy change should contact the RCVS Education Department on cpd@rcvs.org.uk
A full range of FAQs on the COVID-19 pandemic and the impact on the veterinary profession are available to view at www.rcvs.org.uk/coronavirus
Mars says that during a typical anaesthetic procedure, less than five percent of the volatile anaesthetic agent delivered to a patient is absorbed and metabolised and about 95% is exhaled.
SageTech’s gas-capture technology – which is currently used in human healthcare – works by capturing the waste anaesthetic agent exhaled during an operation by adsorbing it into a reusable capture canister.
These waste anaesthetic agents can then be extracted from the filter, without incinerating or release them into the atmosphere.
Ellie West, RCVS and EBVS® European Specialist in Veterinary Anaesthesia and Analgesia, and Linnaeus Environmental Sustainability Lead, said: “As a leading provider of veterinary care, we have a responsibility to take climate action at scale and lead the way toward more sustainable practices.
“Our innovative collaboration should help us take a significant step forward in our sustainability journey, aimed at contributing to a better future for the planet – and the people and pets who depend on it.”
The one-year pilot will start with 10 Linnaeus primary care and referral veterinary practices in the UK, after which Mars says it plans to explore the potential application of this technology across other parts of its business.
https://www.sagetechveterinary.com
Novartis Animal Health has announced that it will begin marketing and distributing Adequan Equine in the UK from January 2011.
According to the company, Adequan Equine offers equine veterinarians a proven intramuscular treatment option for equine degenerative joint disease, also known as non-infectious arthritis or osteoarthritis. The product is licensed in the UK for the treatment of lameness in horses due to traumatic or degenerative aseptic joint disease and acute superficial digital flexor tendonitis. This is a critical treatment area since equine degenerative joint disease is estimated to cause up to one-third of all equine lameness cases1. It most commonly affects the hocks and coffin joints with the most severe effects on the high-motion knee and fetlock joints.
Esther Rawlinson MRCVS, Global Technical Services Manager for the Novartis Animal Health Companion Animal Business in the Therapeutics & Equine areas said: "Adequan Equine is a leading joint treatment for horses and is widely used by veterinarians in the equine sport industry. Adequan Equine reduces pain and lameness in horses while at the same time stimulating cartilage repair.
Adequan Equine 100mg/ml solution contains polysulphated glycosaminoglycan for intramuscular injection. It is a chondroprotective, meaning it inhibits the breakdown of cartilage in diseased joints while at the same time supporting its repair.
Adequan Equine works by blocking the destructive enzymes formed in the joint as a result of inflammation while stimulating the production of hyaluronic acid to restore the synovial fluid, and the synthesis of cartilage building compounds.
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
The WSAVA is calling on veterinary surgeons around the world and anyone with an interest in veterinary – and human – medicine to sign the petition to ensure access to ketamine in the face of lobbying by some countries, principally China, to have it put under international scheduling.
According to the WSAVA, proposals for international control stem from the misconception that ketamine is merely a 'recreational drug.' The WSAVA says this is inaccurate and devalues its huge contribution to human and animal medicine.
Dr Walt Ingwersen, WSAVA President Elect and Member of the WSAVA’s Global Pain Council, said: "In 2015, the WHO Expert Committee on Drug Dependence (ECDD) stated that the abuse of ketamine does not cause a global public health threat and that control would limit access for those using it as an anaesthetic. This view was confirmed at a meeting of the UN Commission on Narcotic Drugs in March 2016, helped by strong support view from the global medical and veterinary communities. However, China has repeated its view that ketamine should fall under international scheduling and we have no doubt that it will raise the issue again. This mean the risk to ketamine remains."
He added: "Ketamine is a safe anaesthetic which can be used without oxygen, ventilators, electricity and the support systems required for other products, making it the only anaesthetic suitable for both medical and veterinary use in lower and middle income countries. If developing countries were denied access to it, which would be the effect of international scheduling, the effects on veterinary medicine, human health and animal welfare would be devastating."
Dr Ganga de Silva, President of the Society of Companion Animal Practitioners of Sri Lanka, said: "Sri Lanka is a poor country with an underdeveloped veterinary profession. If ketamine was not available, in my opinion, all surgeries would have to cease as almost all of the veterinarians in the country rely on it for anaesthesia. The result would be suffering for animals and it would also seriously impact our ability to control rabies as we would not be able to carry out spay and neuter programs on stray dogs."
Dr Nancy Shaffran CVT, VTS(ECC), President of the International Veterinary Academy of Pain Management, said: “In addition to its use as an anaesthetic agent, ketamine is a critical medication used in the pain management in animals. The mechanism of action of ketamine (NMDA receptor antagonism) delivered as a Constant Rate Infusion has been well established to be effective in the prevention and correction of severe neuropathic pain and spinal cord wind-up. The loss of ketamine in veterinary practice would result in the needless suffering of many patients and we strongly oppose this action. We are very grateful for WSAVA’s efforts to keep ketamine available for our patients."
Dr Walt Ingwersen added: "Ketamine is also used in human medicine as it has a particular value for use 'in the field' - for instance, in treating trauma patients, those with traffic and sporting injuries or affected by natural disasters and conflict. Taking these factors together, it is clear that ketamine is an essential medicine and we are determined to ensure that it remains freely available. We are continuing to harness our global veterinary community to highlight the importance of ketamine because this is a battle our patients can’t afford us to lose. We ask all those agreeing with to sign our petition and help our collective voice grow."
The petition is here: http://chn.ge/1RFSou6.
The WSAVA’s Global Pain Council has produced a range of tools and resources, including an infographic, to support its ketamine campaign. They can be accessed here: http://www.wsava.org/educational/global-pain-council
Petplan has revealed the top 10 most claimed for health conditions in cats and dogs for 2011.
They were:
Two veterinary surgeons from the Animal Health Trust have won international awards for outstanding work in diagnostic imaging at 16th International Veterinary Radiology Association (IVRA) meeting held in Bursa Turkey.
Dr Sue Dyson, Head of Clinical Orthopaedics at the AHT, was awarded the IVRA J Kevin Kealy Award, which recognises members of the IVRA who have made substantial, scientific contributions to veterinary radiology.
The Award, established in 2003, is named in honour of Emeritus Professor J. Kevin Kealy, organiser of the first meeting of the IVRA, the first President, and an Honorary Member of the Association.
Sue has lectured internationally and published more than 200 refereed papers in scientific journals, as well as being a major author and editor of four books. On receiving the award, she said: "I was hugely surprised to receive this award and feel extremely honoured."
Past president of the IVRA, Peter Lord, said: "It is hard to imagine that equine diagnostic imaging today would be the same without the contributions of Sue Dyson and her colleagues. She is an outstanding recipient of the J Kevin Kealy Award."
Ruth Dennis, Head of Diagnostic Imaging (pictured above right), was awarded the European Association of Veterinary Diagnostic Imaging (EAVDI) Douglas and Williamson Award, established in 1983, to recognise outstanding achievement within the field of veterinary diagnostic imaging.
Ruth was President of the EAVDI between 2000 and 2002 and her long standing contributions to the association have been recognised with this award.
Ruth said: "I am very honoured to receive this award, especially since, as a vet student in Cambridge in the late 1970s, I was taught by Sidney Douglas and David Williamson, who were pioneers of veterinary radiology."
Nuria Corzo-Menendez, current EAVDI President, said: "Ruth's contributions to veterinary diagnostic imaging are vast and we will always be grateful for such great additions to our field."
Norbrook has announced the launch of Spotinor Deltamethrin spot-on, a new product which kills a wide range of external parasites that can have economically damaging effects on cattle, sheep and lambs.
The product is effective against lice and flies on cattle, ticks, lice, keds and established blowfly strike on sheep, and lice and ticks on lambs. It is available in 250ml and 500ml squeeze neck dispensing packs as well as a 1 litre and 2.5 litre backpack with dosing gun. The dose is 10ml for cattle, 5ml for sheep and 2.5ml for lambs (under 10kg/1 month of age).
Spotinor has a zero milk withhold time.
Edward Haughey, Director of Norbrook GB, said: "As Britain's leading veterinary pharmaceutical company, Norbrook is committed to providing British farmers and vets with the products and services they need to manage animal health effectively. Spotinor is the first generic to market, which displays the same benefits as the pioneer product. We are delighted to launch Spotinor, which gives livestock producers a greater choice of safe and sound solutions for the control of external parasites."
For more information, contact your Norbrook representative, telephone +44 (0) 1536 741 147 or email: enquiries@norbrook.co.uk
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-prick sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
Reference
The collection draws together a selection of materials, including chapters from BSAVA Manuals, articles from Companion, webinars and Congress lectures.
The collection is divided into four areas: general information, client communication, client support and practitioner support. It includes things like:
Julian Hoad, Chair of the BSAVA Publications Committee said: “Death and taxes are the only two certainties of life, according to Benjamin Franklin! Our pets don’t have the worry of taxation but managing the end of life for them is something that all owners must face. It is probably the most challenging part of our veterinary work also – managing the emotional, sometimes highly charged, aspect of the situation, whilst maintaining an objective focus on the patient.
"This new collection provides a handy resource for this important area of veterinary practice. The collection will enable the recent graduate to gain confidence in dealing with these cases; tips for improvement that even the more experienced clinician will find useful are also included.”
The collection can be accessed via the BSAVA Library https://www.bsavalibrary.com/content/end-of-life---introduction at a cost of £20.00 for BSAVA members or £45.00 for non-members.
Virbac says this is the only wet product to provide separate species-specific dog and cat convalescence diets tailored to the unique nutritional needs of both species.
In an internal study conduct by Virbac, 86% of dogs with digestive issues improved within a week of using the diet1
The new diets are high in protein and low in carbohydrate and they can be used alone or in combination with the company's dry diets (suggested 50/50 split).
Andrew Connolly, Marketing Director – UK & Ireland at Virbac said: “We’re thrilled with the overwhelmingly positive feedback we've received on our new Veterinary HPM Digestive Support wet diets.
“Practices and pet owners alike are commenting on the extraordinary palatability of the diets and their effectiveness, particularly with convalescing and inappetent pets”.
References
VetSurgeon.org member, Martin Atkinson MRCVS has had his first book, A Test of Patients, published on Amazon Kindle (£6.59).
Described as the experiences and musings of a veterinary surgeon, the book is a collection of anecdotes collected over the period since Martin qualified from Liverpool in 1975 up until his more recent self-appointed sainthood (or not, as the case may be), as the owner of St Martin's Veterinary Clinic.
Martin said: "This book is a collection of short stories recording some of the more entertaining aspects of my veterinary career plus one or two fantasies and musings. It is meant to be amusing but also carries some serious messages. It is illustrated in a suitable quirky way by my daughter Alice.
"This book has been a labour of love rather than a commercial enterprise and has not been professionally proof read or edited so there are one or two typos and formatting bloomers including one in the very first sentence! I hope this dos not detract from the reader's enjoyment".
Limited signed copies of the book are also available direct from the author (£8.99 inc p&p) by emailing your details to: martin@gconnect.com.
Martin is donating earnings from the book to animal charities, including Cats Protection, BSAVA Petsavers, The Dogs Trust and the PDSA.
Agria Pet Insurance has launched a competition in which the practice that creates the most informative and effective pet insurance display using the company's new display kit will win £500 cash.
Agria says its new display kit is designed primarily to help clients understand how pet insurance works, but also allows a practice to include their own patients' case studies and testimonials too.
To order your free display kit, either complete the online order form at www.agriavetcare.co.uk/competition.aspx or call Agria's Veterinary Helpline on 0800 369 90 98
To enter the competition, send a digital photograph of your finished display to vetphotos@agriapet.co.uk together with your practice name and address.
Veterinary surgeons and practice managers will be invited to judge the entries and vote for the winning display at the Veterinary Business & Management Congress in January 2013.
The overall winner will be announced at the BSAVA Congress.
The RCVS has launched an online petition calling on Parliament to protect the title ‘veterinary nurse’ in law.
The petition follows on from the work done by the College earlier in the year, drawing up the ‘Veterinary Nurse (Protection of Title) Bill’ which was submitted to a ballot of the House of Lords in May by former RCVS President and Council member Professor the Lord Trees and received its first reading on 10 June.
Unfortunately, Lord Trees' Bill was drawn low in the ballot, so it is now thought unlikely - though not impossible - that it will be given time for a second reading in this parliament.
Nevertheless, the College is continuing to try and raise awareness of the issue, both amongst the public and parliamentarians. If the petition gains enough signatures, it should maximise the chances of the Bill being given a proper airing in parliament, this year or in the future.
Liz Cox, the Chair of VN Council, said: “We believe that the fact that anybody can call themselves a veterinary nurse is unacceptable. It means that there is potential for the public to be misled and for animal health and welfare to be compromised. Therefore we would urge veterinary nurses, veterinary surgeons and animal owners to sign this petition. With 10,000 signatures the Government is obliged to respond formally and take a stance on the issue; with 100,000 signatures the issue would be considered for a formal parliamentary debate.
“If we are successful with this campaign, the public will be assured that they are receiving the highest standard of nursing care for their animals from a genuine professional and by protecting the title we can remove any doubt about who is a veterinary nurse.”
In conjunction with the petition, the RCVS has also produced a template letter which the profession and public can use to write to their local Member of Parliament asking them to support the campaign. For example, the letter asks the MP to adopt the Veterinary Nurse (Protection of Title) Bill and enter it into a Private Members’ Bill ballot or introduce it as a 10-Minute Rule Bill.
The petition, and the campaign in general, has received support from the BVNA and the British Veterinary Association BVA.
Fiona Andrew, President of the BVNA, said: “BVNA has campaigned for the protection of the title of 'Veterinary Nurse' for many years. We are delighted that the RCVS is continuing the campaign with the addition of the online petition and letter template.
“We would ask all out members to sign the petition and write to their MP. We believe that this is an important step towards giving clarity and reassurance to the public, strengthening the profession and raising awareness of what veterinary nurses can do and enhancing animal welfare.”
John Blackwell, President of the BVA, added: “BVA is delighted to support the campaign to protect the title, as veterinary nurses are an essential part of the veterinary team and deserve full recognition for their roles. By protecting the title it not only recognises the skills of qualified veterinary nurses, but also gives clients confidence that their animals are receiving the highest standard of care possible.” Those who wish to sign the petition can do so on the UK Government and Parliament petition website https://petition.parliament.uk/petitions/106153 To find out more about the campaign, download a template letter to an MP and view the College's animated video about protecting the title, visit www.rcvs.org.uk/vntitle
The survey, which was designed to give veterinary surgeons and employers a greater insight in order to be able to attract the highest calibre applicants, was completed by 206 veterinary nurses who described themselves as having recently looked for a job, or actively looking for a job, or could imagine looking for a job in the foreseeable future.
The second most important job attribute cited by veterinary nurses - out of 13 - was ‘pay’, with ‘work-life balance’ in third.
Interestingly, when asked a similar question, veterinary surgeons said ‘pay’ was only the 6th most important factor, perhaps a reflection of the fact that a reasonable salary is more of a given amongst veterinary surgeons than nurses.
The survey also found that only slightly more veterinary nurses are prepared to do out-of-hours work than veterinary surgeons: 58% versus 52%.
Lastly, the survey showed that nurses may be more internet-savvy than veterinary surgeons, with an overwhelming majority (85%) said they were likely to spend most time browsing jobs online, as opposed to traditional magazines (compared to nearly 70% of veterinary surgeons that said the same).
VetSurgeon.org/VetNurse.co.uk Editor Arlo Guthrie said: "The survey was carried out primarily to help practices create recruitment adverts that better meet the hopes and aspirations of candidates, thereby improving response rates.
"I think it provides clear evidence of the need for advertisements to give examples of how you show you value your nurses, such as support for further education, a system which allows their voices to be heard and good ideas implemented, and team-building events.
"And if you pay well, don’t be shy about staying so."
The full survey results can be downloaded here.
Thousands of shipments of equine germinal product (semen, ova or embryos) are imported into the UK every year. It is a legal requirement for all imported equine semen to be accompanied to the place of destination (usually to the side of the mare) by an original, valid health certificate (ITAHC), issued in the country of origin.
The BEVA says that recently, consignments of equine semen have been imported without the appropriate health certificates meaning that there is no guarantee that the semen is free from the stated diseases or even that it is from the chosen stallion.
According to the Association, some well-known importing agents have been advising mare owners that these certificates are unnecessary and openly criticising veterinary surgeons who refuse to inseminate mares with uncertified imported semen.
The use of uncertified semen risks recipient mares being infected with diseases such as CEM or EVA, the potentially rapid spread of disease in breeding stock and eventual restrictions being placed on breeding premises. Recent outbreaks of Equine Infectious Anaemia (EIA) in Europe have increased the threat to the UK herd.
The personal and professional reputation of any veterinary surgeon involved with using uncertified semen is also in danger, with the RCVS likely to take a stringent line with any vets who disregard animal health laws and the high health status of British horses.
Malcolm Morley, Partner at Stable Close Equine Practice was recently placed in a difficult position with a longstanding client when semen arrived without the requisite documentation. Following a discussion between the semen importer and his client, where the client was told that Malcolm was being pedantic and that the client should find someone else to inseminate the mare, Malcolm contacted the importer saying: "We have no intention of inseminating the mare without the correct health papers. Please will you ensure that when you speak to the mare’s owner that you make it clear that you do not expect us to inseminate the mare in these circumstances and that the health papers should have been shipped with the semen."
Another BEVA member who wishes to remain anonymous said: "I have one very big client I think I may be about to lose because of my refusal to inseminate his mare without papers … (the importing stud) did not feel it worth a three hour drive to get papers done. The semen importer has made it clear to my client that (they believe) I am just being awkward."
Mark Bowen Senior Vice president of BEVA said: "Import agencies have placed additional pressure on the vets to inseminate mares without the necessary paperwork. Not only is this action illegal but places recipient mares under a direct threat from a notifiable and incurable disease. This seems particularly cavalier given the recent outbreaks of EIA across Europe."
Tullis Matson, Founder and Managing Director of Stallion AI Services said: "No one should be inseminating mares with imported semen that isn’t accompanied by the original health certificate. If the UK wants to retain its high health status and continue to utilise the international market it needs the breeding industry and the veterinary profession to use the disease controls that are currently place until such a time as we can implement more efficient system."
The BEVA says it is taking the following action:
The SPVS Salary Survey provides a benchmark of remuneration levels in the profession, including basic earnings, bonuses, dividends, overtime, accommodation, car allowances and pensions.
The main survey findings will be published in a report which will be shared with anyone who takes part and gives their email address at the end of the survey.
SPVS members will be given the full results with additional commentary and analysis.
The Association says all responses are treated as strictly anonymous and totally confidential, and thanks everyone in advance who decides to take part.
To take part, visit: https://spvs.org.uk/salary-survey-2021.
If you have any questions about the survey, email office@spvs.org.uk.
Defra / APHA will provide an update on the current situation, followed by a presentation about BTV by Peter Mertens, Professor of Virology, University of Nottingham, and Christopher Sanders, Research Fellow in Veterinary Entomology from the Pirbright Institute.
If can't attend, you can register to be sent a recording afterwards.
This is the first of a series of bluetooth update webinars which will be held fortnightly on Wednesdays at 6pm.
https://ahdb.org.uk/events/bluetongue-virus-technical-webinar
Janssen Animal Health has highlighted that enforcement of the Veterinary Medicines legislation will require thousands of poultry owners to change the way they worm in the future.
The company says that in the past many poultry keepers with small to medium sized flocks have used Flubenvet® 2.5% Medicated Premixture 240 gram pack. However, going forwards, it will no longer be possible to do so unless individuals (or companies) are approved and registered to mix medicines into feed. The Flubenvet® 1% 60 gram pack for domestic poultry launched in 2008 remains widely available and can still be used without having to register. Each 60 gram pack is suitable to treat around 20 chickens.
Registered retailers are also only able to sell medicated premixtures for mixing into more than 30kg of feed to customers who are specifically registered with the VMD to mix these into animal foods.
Janssen Animal Health vet Nigel Underwood said: "We are advising all poultry keepers of this legislation. We must comply with the law and are simply not able to supply unregistered wholesalers, merchants, pharmacies of vet practices with medicated premixtures unless they are approved.. The new 60 gram domestic poultry pack of Flubenvet® 1% was developed specifically for the smaller poultry owner and is exempt from the legislation. It is available from vets, pharmacists and suitably qualified animal health advisers and poultry owners do not have to be registered to use it."